Drug intelligence / Profile preview

2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide is a synthetic chemical compound. Its precise mechanism of action and primary therapeutic indications are not widely documented in publicly available scientific literature under a common name. It belongs to the class of imidazo[1,2-a]pyridine and pyrimidine derivatives, which are known to exhibit a range of biological activities, including anticancer and antimicrobial properties, and have been explored as inhibitors of various kinases such as FLT3 and cyclin-dependent kinases. However, specific details regarding the development, clinical trials, or approved uses for this exact compound are not readily available. It is likely an experimental or research compound.

02

Targets

PDGFRA V651D (Platelet-derived growth factor receptor alpha (PDGFRα) V651D mutant)KIT (c-KIT proto-oncogene receptor tyrosine kinase)IRAK4 (Interleukin-1 receptor associated kinase 4)

Beyond the preview

Go deeper on 2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call